IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q3 2023 Holdings

Filed 2023-11-14 | 3 holdings | $284.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ambrx Biopharma IncSPONSORED ADS02290A102$191.9M16,688,63667.5%
Immunovant Inc(IMVT)COM45258J102$69.8M1,818,37124.6%
Argenx SE(ARGX)SPONSORED ADR04016X101$22.4M45,6157.9%